Landmark trials in endocrine adjuvant therapy for breast carcinoma.
The review summarizes the outcomes of several landmark trials involving aromatase inhibitors that helped formulate current therapeutic approaches recommended by the American Society of Clinical Oncology for breast carcinoma treatment.
Gradishar
William
W
Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. w-gradishar@northwestern.edu
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D017410:Practice Guidelines as Topic
D018931:Antineoplastic Agents, Hormonal